logo
logo

London Biotech Baseimmune Closes £3.5M Funding, Eyes To Develop Future-Proof Universal Vaccines

London Biotech Baseimmune Closes £3.5M Funding, Eyes To Develop Future-Proof Universal Vaccines

11/02/21, 12:00 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/CA.svglondon
Money raised
£3.5 million
Round Type
seed
The COVID-19 pandemic has fuelled a renaissance in vaccine research, underpinned by the creation of novel vaccine delivery systems and robust worldwide manufacturing pipelines, with the global vaccine market predicted to reach $108 billion by 2027.

Company Info

Company
Baseimmune
Location
london, ontario, canada
Additional Info
The proceeds of this round will be enable the company to grow, develop more vaccines in parallel and further expanding the number of diseases it is able to tackle.